SPRY EPS Estimates
ARS Pharmaceuticals, Inc.
$4.56
+$0.20(+4.59%)
34
Overall
50
Value
18
Tech
34
Quality
Market Cap
$433.59M
Volume
1.58M
52W Range
$3.99 - $13.15
Target Price
$24.33
SPRY EPS estimates: the consensus estimate for ARS Pharmaceuticals, Inc.'s current fiscal year is -$1.90 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
SPRY EPS Estimates
- EPS estimate, current quarter
- $-0.33
- EPS estimate, next quarter
- $-0.34
- EPS estimate, current year
- $-1.90
- EPS estimate, next year
- $-0.88
- EPS growth, 3-year
- -25.99%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.74 |
| 2024 | $0.08 |
| 2023 | $-0.57 |
| 2022 | $-0.87 |
| 2021 | $-2.56 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SPRY | $4.56 | +4.6% | 1.58M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ARS Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW